tradingkey.logo

Lab instruments maker Agilent's Q4 revenue beats estimates

ReutersNov 24, 2025 9:20 PM


Overview

  • Agilent Q4 fiscal revenue grows 9.4%, beating analyst expectations

  • Adjusted net income for Q4 slightly beats analyst expectations

  • Company provides optimistic FY26 guidance, expecting revenue growth of 5% to 7%


Outlook

  • Agilent expects FY26 revenue between $7.3 bln and $7.4 bln

  • FY26 non-GAAP EPS expected between $5.86 and $6.00

  • Q1 FY26 revenue guidance between $1.79 bln and $1.82 bln


Result Drivers

  • LIFE SCIENCES GROWTH - Life Sciences and Diagnostics Markets Group reported 15% revenue growth, driven by strong demand

  • OPERATIONAL EFFICIENCIES - Expanded Ignite Operating System enhanced operating efficiencies, fueling innovation and commercial execution


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$1.86 bln

$1.83 bln (12 Analysts)

Q4 EPS

$1.53

Q4 Adjusted Net Income

Slight Beat*

$452 mln

$449.42 mln (11 Analysts)

Q4 Net Income

$434 mln

Q4 Pretax Profit

$442 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Agilent Technologies Inc is $150.00, about 0.8% below its November 21 closing price of $151.25

Press Release: ID:nBw6q480Ba

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI